These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5391587)

  • 1. [Examination of the plasma clotting activities--determination of contact factors XII, XI].
    Murakami M; Umeda T
    Rinsho Byori; 1969; 16():Suppl 16:66-74. PubMed ID: 5391587
    [No Abstract]   [Full Text] [Related]  

  • 2. [A method of studying the contact phase of blood coagulation].
    Zubairov DM; Popova LG
    Lab Delo; 1969; 8():471-3. PubMed ID: 4193035
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contact factors (factor XII and XI)--how to read its figures].
    Matsuoka M; Ito M
    Nihon Rinsho; 1971 Jan; 29():Suppl:624-8. PubMed ID: 4928293
    [No Abstract]   [Full Text] [Related]  

  • 4. [Contact coagulation factors].
    Kojima T; Saito H
    Rinsho Byori; 1987 Apr; Spec No 70():79-87. PubMed ID: 3302400
    [No Abstract]   [Full Text] [Related]  

  • 5. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
    Mischke R; Deniz A; Nolte I
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinin system of human plasma. IV. The interrelationship between the contact phase of blood coagulation and the plasma kinin system in man.
    Ozge-Anwar AH; Movat HZ; Scott JG
    Thromb Diath Haemorrh; 1972 Feb; 27(1):141-58. PubMed ID: 5033664
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activity of the contact substance in thromboplastin formation in the full-term newborn infant].
    Schettini F; Wierdis T; Lattanzi E; Violante N; Zimbalatti F
    Boll Soc Ital Biol Sper; 1966 Aug; 42(16):1058-60. PubMed ID: 5969468
    [No Abstract]   [Full Text] [Related]  

  • 8. Congenital deficiency of Hageman factor (clotting factor XII). Report on the first two families found in Switzerland.
    Baumann R; Straub PW
    Helv Med Acta; 1968 Nov; 34(4):313-26. PubMed ID: 5704616
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on contact factors. I. A method for the measurement of "content activity" with artifically depleted normal plasma].
    Umeda T
    Nihon Ketsueki Gakkai Zasshi; 1968 Dec; 31(7):1165-72. PubMed ID: 5753797
    [No Abstract]   [Full Text] [Related]  

  • 10. The possible role of platelets in bypassing the contact phase of blood coagulation.
    Walsh PN; Tuszynski GP; Greengard JS; Griffin JH
    Haematologia (Budap); 1984; 17(2):169-78. PubMed ID: 6534825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the minimal concentrations of contact activation factors in deficient substrate plasmas required to assess accurately factor XII, factor XI, factor IX, and high molecular weight kininogen.
    Munakata M; Teraoka A; Komiyama Y; Masuda M; Murakami T; Murata K
    Thromb Res; 1990 Jan; 57(2):197-203. PubMed ID: 2315884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of procoagulants produced in cell cultures by tests of coagulation.
    Zacharski LR; McIntyre OR
    Thromb Diath Haemorrh; 1971 Dec; 26(3):493-502. PubMed ID: 5144962
    [No Abstract]   [Full Text] [Related]  

  • 13. Method of purification and properties of anti-XIa (inhibitor of the contact product).
    Niemetz J; Nossel HL
    Thromb Diath Haemorrh; 1967 May; 17(3-4):335-48. PubMed ID: 5589293
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on contact factors. II. Contact activities in various diseases].
    Umeda T
    Nihon Ketsueki Gakkai Zasshi; 1968 Dec; 31(7):1173-9. PubMed ID: 5753798
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and experimental studies on the contact factor. I. Contact factor activity in various dieases].
    Ito M
    Nihon Ketsueki Gakkai Zasshi; 1968 Dec; 31(7):1142-54. PubMed ID: 5753795
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the KC10 semi-automatic modular clot detection device].
    Crespo B; Ankri A; Lesty C
    Nouv Rev Fr Hematol (1978); 1983; 25(2):113-21. PubMed ID: 6408609
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prothromboplastin factor group (factors VIII, IX, XI, XII)--interpretation of the test results].
    Kagami M
    Nihon Rinsho; 1973; 31():1721-33. PubMed ID: 4795303
    [No Abstract]   [Full Text] [Related]  

  • 18. [The activity of the contact substance in thromboplastin formation in the premature infant].
    Schettini F; Violante N; Lattanzi E; Mautone A
    Boll Soc Ital Biol Sper; 1966 Aug; 42(16):1060-3. PubMed ID: 5969469
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors XI and XII are low in subjects with liver disease.
    Walker IR; Milner RA; Johnston MA; Rand CA; Neame PB; Hirsh J
    Dig Dis Sci; 1983 Nov; 28(11):967-70. PubMed ID: 6628156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors XI and XII and prekallikrein in sick and healthy premature infants.
    Andrew M; Bhogal M; Karpatkin M
    N Engl J Med; 1981 Nov; 305(19):1130-3. PubMed ID: 6912944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.